Lessee, Operating Lease, Liability, to be Paid, Year Three in USD of Sonnet BioTherapeutics Holdings, Inc. from Q1 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and change rate from Q1 2019 to Q3 2023.
  • Sonnet BioTherapeutics Holdings, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 30 Sep 2023 was $48,216, a 49.5% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)

Sonnet BioTherapeutics Holdings, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $48,216 -$47,271 -50% 30 Sep 2023 10-K 14 Dec 2023 2023 FY
Q3 2022 $95,487 30 Sep 2022 10-K 15 Dec 2022 2022 FY
Q2 2022 $95,487 +$60,792 +175% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q3
Q2 2021 $34,695 $0 0% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q3
Q1 2021 $34,695 31 Mar 2021 10-Q 17 May 2021 2021 Q2
Q4 2020 $34,695 -$3,118,590 -99% 31 Dec 2020 10-Q 16 Feb 2021 2021 Q1
Q3 2020 $34,695 30 Sep 2020 10-K 17 Dec 2020 2020 FY
Q2 2020 $34,695 30 Jun 2020 10-Q 14 Aug 2020 2020 Q3
Q4 2019 $3,153,285 31 Dec 2019 10-K 19 Mar 2020 2019 FY
Q1 2019 $3,723,305 31 Mar 2019 10-Q 15 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.